Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Safety and Efficacy of Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

NCT04906070 is registered in ClinicalTrials.gov with Hekabio as lead sponsor.

NCT NCT04906070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Safety and Efficacy of Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan
Lead sponsor
Hekabio
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2019
Completion date
May 27, 2022
Enrollment
14 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, head and neck cancer